Risk assessment in relation to the detection of small pulmonary nodules

Translational Lung Cancer Research

Volumn 6, Issue 1, 2017, Pages 35-41

  Field, John K ^a   Marcus, Michael W ^a   Oudkerk, Matthijs ^b  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Lung cancer; Management; Pulmonary nodules; Risk prediction

Indexed keywords

CANCER MORTALITY; CANCER SCREENING; CLINICAL TRIAL (TOPIC); FALSE POSITIVE RESULT; HUMAN; LUNG CANCER; LUNG NODULE; MEDICAL SOCIETY; PRACTICE GUIDELINE; PREDICTIVE VALUE; REVIEW; RISK ASSESSMENT; SCREENING TEST; SENSITIVITY AND SPECIFICITY; THORAX RADIOGRAPHY; UNITED STATES; X-RAY COMPUTED TOMOGRAPHY;

EID: 85014384105     PISSN: 22186751     EISSN: 22264477     Source Type: Journal    
DOI: 10.21037/tlcr.2017.02.05     Document Type: Review

References (25)

1. Henschke CI, McCauley DI, Yankelevitz DF, et al. Early Lung Cancer Action Project: overall design and findings from baseline screening. Lancet 1999;354:99-105.
2. National Lung Screening Trial Research T, Aberle DR, Adams AM, et al. Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med 2011;365:395-409.
3. Field JK, Oudkerk M, Pedersen JH, et al. Prospects for population screening and diagnosis of lung cancer. Lancet 2013;382:732-41.
4. Field JK, Hansell DM, Duffy SW, et al. CT screening for lung cancer: countdown to implementation. Lancet Oncol 2013;14:e591-600.
5. Field JK. Perspective: The screening imperative. Nature 2014;513:S7.
6. Field JK, Devaraj A, Duffy SW, et al. CT screening for lung cancer: Is the evidence strong enough? Lung Cancer 2016;91:29-35.
7. USPSTF Lung Cancer Screening [Internet]. 2015 [cited 25-11-2016]. Available online: http://www. uspreventiveservicestaskforce.org/Page/Document/ UpdateSummaryFinal/lung-cancer-screening
8. Decision Memo for Screening for Lung Cancer with Low Dose Computed Tomography (LDCT) (CAG-00439N) [Internet]. Available online: https://www.cms.gov/ medicare-coverage-database/details/nca-decision-memo. aspx?NCAId=274. Cited 25-11-2016.
9. McWilliams A, Tammemagi MC, Mayo JR, et al. Probability of cancer in pulmonary nodules detected on first screening CT. N Engl J Med 2013;369:910-9.
10. Cook NR. Use and misuse of the receiver operating characteristic curve in risk prediction. Circulation 2007;115:928-35.
11. Halligan S, Altman DG, Mallett S. Disadvantages of using the area under the receiver operating characteristic curve to assess imaging tests: a discussion and proposal for an alternative approach. Eur Radiol 2015;25:932-9.
12. Steyerberg EW, Vickers AJ, Cook NR, et al. Assessing the performance of prediction models: a framework for traditional and novel measures. Epidemiology 2010;21:128-38.
13. Al-Ameri A, Malhotra P, Thygesen H, et al. Risk of malignancy in pulmonary nodules: A validation study of four prediction models. Lung Cancer 2015;89:27-30.
14. Herder GJ, van Tinteren H, Golding RP, et al. Clinical prediction model to characterize pulmonary nodules: validation and added value of 18F-fluorodeoxyglucose positron emission tomography. Chest 2005;128:2490-6.
15. Fintelmann FJ, Bernheim A, Digumarthy SR, et al. The 10 Pillars of Lung Cancer Screening: Rationale and Logistics of a Lung Cancer Screening Program. Radiographics 2015;35:1893-908.
16. Pinsky PF, Gierada DS, Black W, et al. Performance of Lung-RADS in the National Lung Screening Trial: A Retrospective Assessment. Ann Intern Med 2015;162:485-91.
17. Li K, Yip R, Avila R, et al. Size and Growth Assessment of Pulmonary Nodules: Consequences of the Rounding. J Thorac Oncol 2016. [Epub ahead of print].
18. van Klaveren RJ, Oudkerk M, Prokop M, et al. Management of lung nodules detected by volume CT scanning. N Engl J Med 2009;361:2221-9.
19. Field JK, Duffy SW, Baldwin DR, et al. The UK Lung Cancer Screening Trial: a pilot randomised controlled trial of low-dose computed tomography screening for the early detection of lung cancer. Health Technol Assess 2016;20:1-146.
20. Horeweg N, van der Aalst CM, Vliegenthart R, et al. Volumetric computed tomography screening for lung cancer: three rounds of the NELSON trial. Eur Respir J 2013;42:1659-67.
21. Horeweg N, van Rosmalen J, Heuvelmans MA, et al. Lung cancer probability in patients with CT-detected pulmonary nodules: a prespecified analysis of data from the NELSON trial of low-dose CT screening. Lancet Oncol 2014;15:1332-41.
22. Walter JE, Heuvelmans MA, de Jong PA, et al. Occurrence and lung cancer probability of new solid nodules at incidence screening with low-dose CT: analysis of data from the randomised, controlled NELSON trial. Lancet Oncol 2016;17:907-16.
23. Callister ME, Baldwin DR, Akram AR, et al. British Thoracic Society guidelines for the investigation and management of pulmonary nodules. Thorax 2015;70 Suppl 2:ii1-ii54.
24. Baldwin DR, Devaraj A. Lung cancer risk in new pulmonary nodules: implications for CT screening and nodule management. Lancet Oncol 2016;17:849-50.
25. Field JK, Duffy SW, Devaraj A, et al. Implementation planning for lung cancer screening: five major challenges. Lancet Respir Med 2016;4:685-7.